The United Kingdom's approval of India-made COVID-19 vaccine Covaxin came into effect on Monday, 22 November.
The country had on 8 November said it would recognise all COVID-19 vaccines on the World Health Organization's approved list from 22 November.
The Technical Advisory Group of the WHO had, on 3 November, said that it had recommended Emergency Use Listing (EUL) status for Bharat Biotech's Covaxin.
Reacting to this development, Covaxin maker Bharat Biotech had said the Emergency Use Listing approval by WHO "validates the international safety and quality standards of COVAXIN".
The Quint answers all your questions about Covaxin approval in the UK.
What does Covaxin approval mean?
The travellers to the UK fully inoculated with Covaxin will no longer be required to isolate on arrival in the country.
When will the changes be implemented?
The new rule will come into effect at 4 pm on 22 November.
I have taken one dose of Covaxin. Can I travel to the UK?
You will be considered 'unvaccinated' and will have to follow the 10-day quarantine protocol, along with getting a pre-departure COVID-19 test.
Which other India-manufactured vaccine has been approved by the UK?
With the UK's announcement, Covaxin will join the ranks with the Serum Institute of India (SII)-manufactured Covishield.
In early October, the UK had announced that Indians travelling to the UK fully vaccinated with Covishield or any other UK-approved vaccine would not be required to quarantine on arrival.
How many vaccines on WHO's Emergency Use Listing are approved by the UK government this time?
In addition to Covaxin, China's Sinovac and Sinopharm were also approved by the UK for travellers from other countries.
Will you be required to take a COVID-19 test before departure?
Fully vaccinated travellers will not be required to take a pre-departure test.
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)